Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
Janssen Research & Development, LLC
David T Rubin; Jessica R Allegretti; Julián Panés; Nicole Shipitofsky; Shadi S Yarandi; Kuan-Hsiang Gary Huang; Matthew Germinaro; Rebbecca Wilson; Hongyan Zhang; Jewel Johanns; Brian G Feagan; Tadakazu Hisamatsu; Gary R Lichtenstein; Brian Bressler; Laurent Peyrin-Biroulet; Bruce E Sands; Axel Dignass; QUASAR Study Group